ArticleFrontiers in immunology2025

A novel carboxamide bromodomain inhibitor attenuates osteoarthritis via epigenetic repression of NF-κB and MAPK signaling.

Hyemi Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.